KALV — Price & Forward EBITDA

Forward EBITDA (M)

Float Short %

51.54

Margin Of Safety %

Put/Call OI Ratio

0.52

EPS Next Q Diff

EPS Last/This Y

2.74

EPS This/Next Y

2.01

Price

20.13

Target Price

34.33

Analyst Recom

Performance Q

28.48

Upside

-795.8%

Beta

-0.39

Ticker: KALV

16 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-03-09	KALV	17.29	1.51	0.00	18719
2026-03-10	KALV	18.42	1.51	0.02	18723
2026-03-11	KALV	18.23	1.41	0.01	19273
2026-03-12	KALV	17.4	1.37	2.48	19517
2026-03-13	KALV	17.38	1.37	2.19	19517
2026-03-17	KALV	16.56	1.34	0.20	19649
2026-03-18	KALV	15.49	1.34	0.05	19672
2026-03-20	KALV	17	1.33	4.48	19762
2026-03-25	KALV	17.11	1.45	0.15	17578
2026-03-26	KALV	18.83	1.45	0.00	17597
2026-03-27	KALV	19.3	0.71	0.02	24987
2026-03-30	KALV	18.37	0.53	0.55	30512
2026-03-31	KALV	20.15	0.53	0.13	30686
2026-04-01	KALV	19.76	0.53	0.00	30750
2026-04-06	KALV	20.28	0.53	0.00	30789
2026-04-07	KALV	20.13	0.52	0.28	30916
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

16 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-03-09	KALV	17.29	-	-	-
2026-03-10	KALV	18.43	-	-	-
2026-03-11	KALV	18.22	-	-	-
2026-03-12	KALV	17.39	-	-	-
2026-03-13	KALV	16.95	-	-	-
2026-03-17	KALV	16.58	-	-	-
2026-03-18	KALV	15.51	-	-	-
2026-03-19	KALV	16.44	-	-	-
2026-03-20	KALV	17.03	-	-	-
2026-03-23	KALV	16.59	-	-	-
2026-03-24	KALV	16.49	-	-	-
2026-03-25	KALV	17.11	-	-	-
2026-03-26	KALV	18.97	-	-	-
2026-03-27	KALV	19.30	-	-	-
2026-03-30	KALV	18.35	-	-	-1.34
2026-03-31	KALV	20.14	-	-	-1.34
2026-04-01	KALV	19.76	-	-	-1.34
2026-04-02	KALV	19.90	-	-	-1.34
2026-04-06	KALV	20.20	-	-	-0.95
2026-04-07	KALV	20.13	-	-	-0.95
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-03-09	KALV	-0.66	11.73	53.21
2026-03-10	KALV	-0.61	11.73	53.21
2026-03-11	KALV	-0.66	11.73	51.82
2026-03-12	KALV	-0.66	11.73	51.82
2026-03-13	KALV	-0.66	11.73	51.82
2026-03-18	KALV	-0.66	11.75	51.82
2026-03-19	KALV	-0.66	11.75	51.82
2026-03-20	KALV	-0.66	11.75	51.82
2026-03-23	KALV	-0.66	11.76	51.82
2026-03-24	KALV	-0.66	11.76	51.82
2026-03-25	KALV	-0.66	11.76	52.23
2026-03-26	KALV	-0.66	11.76	52.23
2026-03-27	KALV	-2.19	11.76	52.23
2026-03-30	KALV	-2.19	11.77	51.54
2026-03-31	KALV	-2.19	11.77	51.54
2026-04-01	KALV	-2.19	11.77	51.54
2026-04-02	KALV	-2.19	11.77	51.54
2026-04-06	KALV	-2.19	11.60	51.54
2026-04-07	KALV	-2.19	11.60	51.54
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

-0.4

Avg. EPS Est. Next Quarter

-0.27

Insider Transactions

-2.19

Institutional Transactions

11.6

Beta

-0.39

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

34.4

Max Drawdown 5-Year %

-86

Target Price

34.33

P/E

Forward P/E

42.29

PEG

P/S

720.7

P/B

P/Free Cash Flow

EPS

-4

Average EPS Est. Cur. Y

-0.95

EPS Next Y. (Est.)

1.05

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-14242.57

Relative Volume

1.17

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

0.5

EPS 1 30Days Diff

0.5

EBIT Estimation

◆ KALV Healthcare

$20.12

📉

Swing / Pullback

Buy the dip on strong trends

WEAK

Trend

12/20

Pullback

6/25

Volume

4/15

Valuation

11/20

TP/AR

6/10

Options

7/10

RSI

65.5

Range 1M

81.9%

Sup Dist

2.4%

🚀

Momentum Growth

Ride accelerating trends

WATCH

Momentum

16/25

Growth

24/30

Estimates

6/20

Inst/Vol

11/15

Options

7/10

EPS Yr

53.3%

EPS NY

150.2%

52W%

90.7%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +79.2% upside

Quality

2/30

Valuation

14/30

Growth

19/25

Stability

9/10

LT Trend

4/5

Upside

+79.2%

Quality

KalVista Pharmaceuticals, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 275

KalVista Pharmaceuticals, Inc., a biopharmaceutical company, develops oral therapies for individuals for rare diseases with unmet needs. Its lead product candidate is EKTERLY, a fast-acting potent inhibitor of plasma kallikrein for the treatment of acute attacks of hereditary angioedema (HAE). The company is also developing is developing an orally disintegrating tablet formulation; KONFIDENT-KID for pediatric use with HAE; KONFIDENT; and KONFIDENT-S to evaluate sebetralstat and ODT formulation in adolescent and adult patients. KalVista Pharmaceuticals, Inc. is headquartered in Framingham, Massachusetts.

KALV

Latest News

—

Caricamento notizie per KALV…

stock quote shares KALV – KalVista Pharmaceuticals Inc Stock Price stock today

news today KALV – KalVista Pharmaceuticals Inc stock forecast ,stock prediction 2023 2024 2025

marketwatch KALV – KalVista Pharmaceuticals Inc yahoo finance google finance

stock history KALV – KalVista Pharmaceuticals Inc invest stock market

stock prices KALV premarket after hours

ticker KALV fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: KALV

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y